1.44

0.70% 0.01

After Hours: 1.44

Medicinova Inc (MNOV)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Medicinova Inc stock is traded at $1.44, with a volume of 43,655. It is up +0.70% in the last 24 hours and up +9.92% over the past month. MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.

Previous Close:

$1.43

Open:

$1.45

24h Volume:

43,655

Relative Volume:

1.10

Market Cap:

$70.88M

Revenue:

$409.70K

Net Income/Loss:

$-12.00M

P/E Ratio:

-5.8896

EPS:

-0.2445

Net Cash Flow:

$-9.81M

1W Performance:

+9.92%

1M Performance:

+9.92%

6M Performance:

+4.35%

1Y Performance:

+15.20%

1-Day Range:

$1.41

$1.49

1-Week Range:

$1.29

$1.55

52-Week Range:

$1.168

$1.96

Medicinova Inc Stock (MNOV) Company Profile

Name

Medicinova Inc

Sector

Healthcare (1100)

Industry

Biotechnology (615)

Phone

858-373-1500

Address

4275 EXECUTIVE SQUARE, LA JOLLA, CA

Employee

Twitter

@MedicinovaJapan

Next Earnings Date

2026-08-13

Latest SEC Filings

MNOV's Discussions on Twitter

Compare MNOV vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MNOV Medicinova Inc	1.44	64.97M	409.70K	-12.00M	-9.81M	-0.2445
VRTX Vertex Pharmaceuticals Inc	529.59	126.07B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	649.81	65.37B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	916.80	57.70B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	313.04	40.19B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	189.99	39.82B	742.00K	-1.37B	-1.07B	-7.0731

Medicinova Inc Stock (MNOV) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-16-26	Initiated	H.C. Wainwright	Buy
Mar-10-21	Initiated	Maxim Group	Buy
Mar-25-19	Resumed	B. Riley FBR	Buy
Mar-28-18	Initiated	B. Riley FBR, Inc.	Buy
Apr-18-17	Initiated	Credit Suisse	Outperform
Jan-04-13	Reiterated	Ladenburg Thalmann	Buy
May-24-12	Downgrade	MLV & Co	Buy → Hold
Oct-18-11	Reiterated	MLV Capital	Buy
Jun-22-11	Initiated	Global Hunter Securities	Buy
May-12-10	Initiated	Wedbush	Outperform
Nov-12-08	Reiterated	Ladenburg Thalmann	Buy
May-15-08	Initiated	Rodman & Renshaw	Mkt Outperform
Jul-09-07	Initiated	Punk, Ziegel & Co	Buy

View All

Medicinova Inc Stock (MNOV) Latest News

Jul 01, 2026

Enterprise value to revenue forward of MediciNova, Inc. – TSE:4875 - TradingView

Jul 01, 2026

Price to earnings forward of MediciNova, Inc. – TSE:4875 - TradingView

Jul 01, 2026

Enterprise value to EBITDA forward of MediciNova, Inc. – NASDAQ:MNOV - TradingView

Jul 01, 2026

Jun 30, 2026

MediciNova (MNOV) director Nicole Lemerond receives 44,500 stock options grant - Stock Titan

Jun 25, 2026

MediciNova (MNOV) director receives grant of 44,500 stock options - Stock Titan

Jun 25, 2026